Notable Put Options Activity in Keryx Biopharmaceuticalskerx
Shares of Keryx Biopharmaceuticals (NASDAQ: KERX) are higher on the session by 2.90%, currently trading at $3.19. The stock has been moving largely higher over the past two months and is currently trading above the 50-day moving average.
Options traders are focusing on puts today. The strike seeing the heaviest action is the February 2012 $3.00 put, which has traded 4,500 times on open interest of 4,538 contracts.
Put volume is outpacing call volume by 6 to 1.
Keryx Biopharmaceuticals, Inc. is a biopharmaceutical company focused on the acquisition, development and commercialization of pharmaceutical products for the treatment of cancer and renal disease.
© 2014 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.